FORM 13-G

Company

Alaunos Therapeutics, Inc.

Filed

November 26, 2003

Accession Number

0001049107-03-000032

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →